Medication Safety Issues
Sound-alike/look-alike issues:
SAXagliptin may be confused with SITagliptin, SUMAtriptan
SAXagliptin may be confused with SITagliptin, SUMAtriptan
Generic Available (US)
No
Storage/Stability
Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F).
Adverse Reactions
1% to 10%:
Cardiovascular: Peripheral edema (4%)
Central nervous system: Headache (7%)
Endocrine & metabolic: Hypoglycemia (6%)
Genitourinary: Urinary tract infection (7%)
Hematologic & oncologic: Lymphocytopenia (2%)
Hypersensitivity: Hypersensitivity reaction (2%; including facial edema and urticaria)
Frequency not defined: Cardiovascular: Thrombocytopenia
<1%, postmarketing, and/or case reports: Acute pancreatitis, anaphylaxis, angioedema, bullous pemphigoid, exfoliative dermatitis, immune thrombocytopenia, increased creatine phosphokinase in blood specimen, increased serum creatinine, pancreatitis, rhabdomyolysis, severe arthralgia
